Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...
This week, US health authorities recommended pausing the rollout of the one-shot Johnson & Johnson/Janssen COVID-19 vaccine while investigations into exceptionally rare blood clots take place. Six ...
SHENZHEN, China, Nov. 19, 2021 /PRNewswire/ -- At 3 a.m. on November 19, the first batch of more than 4 million doses of adenovirus vector COVID-19 vaccines produced by Shenzhen Kangtai Biological ...
Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...
The Hearty Soul on MSN
This is why some people had blood clots from the COVID-19 vaccine and others didn't
Rare medical events draw intense attention during any mass vaccination campaign. Among COVID vaccine side effects, few ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Removing non-essential regions like E3 allows additional ...
Researchers in the United States have developed adenovirus vectors that may be more effective at generating immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than ...
The Gene Vector Core was awarded the Blue Flame Award. The award is given to scientists who have at least one plasmid deposited that has been distributed at least 100 times. The Gene Vector Core was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results